SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905718-22-000202
Filing Date
2022-02-10
Accepted
2022-02-10 16:02:58
Documents
1
Group Members
SHAVIT CAPITAL FUND III (US), L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A chemomab_sc13gadec312021.htm SC 13G/A 56335
  Complete submission text file 0000905718-22-000202.txt   58097
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Subject) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86953 | Film No.: 22613842
SIC: 2834 Pharmaceutical Preparations

Mailing Address JERUSALEM TECHNOLOGY PARK BUILDING 1B, BOX 70 MALHA, JERUSALEM L3 9651
Business Address JERUSALEM TECHNOLOGY PARK BUILDING 1B, BOX 70 MALHA, JERUSALEM L3 9651 97226490400
Gabriel Capital Management Ltd. (Filed by) CIK: 0001765871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A